Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Targeted molecular therapeutic options for hepatocellular carcinoma
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeted molecular therapeutic options for hepatocellular carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatocellular Carcinoma
100%
Therapeutic Potential
100%
Liver Cancer
100%
Molecular Therapeutics
100%
Targeted Molecular Therapy
50%
Hepatocellular Carcinoma Patients
50%
Clinical Trials
25%
Chemotherapy
25%
Growth Factor Signaling Pathways
25%
Major Risk Factors
25%
Obesity
25%
Therapeutic Agents
25%
Mode of Action
25%
Kinase Inhibitor
25%
Most Common Form
25%
Cancer Causes
25%
Cancer Mortality
25%
Targeted Therapy
25%
Metabolic Conditions
25%
Tyrosine Kinase
25%
Conventional Chemotherapy
25%
Hepatitis
25%
Advanced Hepatocellular Carcinoma
25%
Lenvatinib
25%
Growth Signaling
25%
Sorafenib
25%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Liver Cancer
80%
Molecularly Targeted Therapy
40%
Chemotherapy
40%
Signal Transduction
20%
Mediator
20%
Malignant Neoplasm
20%
Infection
20%
Side Effect
20%
Clinical Trial
20%
Therapeutic Agent
20%
Phosphotransferase Inhibitor
20%
Growth Factor
20%
Targeted Therapy
20%
Protein Tyrosine Kinase
20%
Lenvatinib
20%
Sorafenib
20%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Liver Cancer
80%
Chemotherapy
40%
Phosphotransferase Inhibitor
20%
Malignant Neoplasm
20%
Side Effect
20%
Growth Factor
20%
Clinical Trial
20%
Infection
20%
Protein Tyrosine Kinase
20%
Sorafenib
20%
Lenvatinib
20%